Author:
Choi Pui-Wah,Bahrampour Abbas,Ng Shu-Kay,Liu Sze Kei,Qiu Wei,Xie Fang,Kuo Winston Patrick,Kwong Joseph,Hales Karen H.,Hales Dale B.,Wong Kwong-Kwok,Norwitz Errol R.,Chow Chun Kin,Berkowitz Ross S.,Ng Shu-Wing
Abstract
AbstractMicroRNA-200 (miR-200) family is highly expressed in ovarian cancer. We evaluated the levels of family members relative to the internal control miR-103a in ovarian cancer and control blood specimens collected from American and Hong Kong Chinese institutions, as well as from a laying hen spontaneous ovarian cancer model. The levels of miR-200a, miR-200b and miR-200c were significantly elevated in all human cancer versus all control blood samples. Further analyses showed significantly higher miR-200 levels in Chinese control (except miR-429) and cancer (except miR-200a and miR141) samples than their respective American counterparts. Subtype-specific analysis showed that miR-200b had an overall elevated level in serous cancer compared with controls, whereas miR-429 was significantly elevated in clear cell and endometrioid cancer versus controls. MiR-429 was also significantly elevated in cancer versus control in laying hen plasma samples, consistent with the fact that endometrioid tumor is the prevalent type in this species. A neural network model consisting of miR-200a/200b/429/141 showed an area under the curve (AUC) value of 0.904 for American ovarian cancer prediction, whereas a model consisting of miR-200b/200c/429/141 showed an AUC value of 0.901 for Chinese women. Hence, miR-200 is informative as blood biomarkers for both human and laying hen ovarian cancer.
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. Reid, F. The World Ovarian Cancer Coalition Atlas- Global Trends in Incidence, Mortality and Survival. (World Ovarian Cancer Coalition, 2018).
2. Vogell, A. & Evans, M. L. Cancer Screening in Women. Obstet. Gynecol. Clin. N. Am. 46, 485–499. https://doi.org/10.1016/j.ogc.2019.04.007 (2019).
3. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2019. CA A Cancer J. Clin. 69, 7–34. https://doi.org/10.3322/caac.21551 (2019).
4. Lu, K. H. Screening for ovarian cancer in asymptomatic women. JAMA 319, 557–558. https://doi.org/10.1001/jama.2017.21894 (2018).
5. Dochez, V. et al. Biomarkers and algorithms for diagnosis of ovarian cancer: CA125, HE4, RMI and ROMA, a review. J. Ovarian Res. 12, 28. https://doi.org/10.1186/s13048-019-0503-7 (2019).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献